Have a personal or library account? Click to login
The impact of microRNA-596 on oral cancer: Insights into tumor biology and treatment strategies Cover

The impact of microRNA-596 on oral cancer: Insights into tumor biology and treatment strategies

Open Access
|Apr 2025

References

  1. Bray F, Laversanne M, Sung H, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2024; 74: 229–263.
  2. Saka-Herrán C, Jané-Salas E, Mari-Roig A, et al. Time-to-Treatment in Oral Cancer: Causes and Implications for Survival. Cancers (Basel) 2021; 13: 1321.
  3. KP A, Kaliaperumal K, Sekar D. microRNAs and their Therapeutic Strategy in Phase I and Phase II Clinical Trials. Epigenomics 2024; 16: 259–271.
  4. Irani S. New insights into oral cancer—Risk factors and prevention: A review of literature. Int J Prev Med 2020; 11: 202.
  5. GAMBARI R, BROGNARA E, SPANDIDOS DA, et al. Targeting oncomiRNAs and mimicking tumor suppressor miRNAs: New trends in the development of miRNA therapeutic strategies in oncology (Review). Int J Oncol 2016; 49: 5–32.
  6. Zhang Z, Dai D-Q. MicroRNA-596 acts as a tumor suppressor in gastric cancer and is upregulated by promotor demethylation. World J Gastroenterol 2019; 25: 1224–1237.
  7. Miñoza JMA, Rico JA, Zamora PRF, et al. Biomarker Discovery for Meta-Classification of Melanoma Metastatic Progression Using Transfer Learning. Genes (Basel) 2022; 13: 2303.
  8. Wang J, Lv N, Lu X, et al. Diagnostic and therapeutic role of microRNAs in oral cancer (Review). Oncol Rep 2020; 45: 58–64.
  9. Huang G, Wu Q, Zheng Z, et al. Identification of Candidate Biomarkers and Analysis of Prognostic Values in Oral Squamous Cell Carcinoma. Front Oncol; 9. Epub ahead of print 18 October 2019. DOI: 10.3389/fonc.2019.01054.
  10. Ahsan M, K P A, Usman P P AS, et al. Computational and expression analysis of microRNA-149-5p and its target, interleukin-6, in chronic kidney disease. Biomedical Research and Therapy 2023; 10: 6103–6109.
  11. Esakki A, Pandi A, Girija SAS, et al. Correlating the genetic alterations and expression profile of the TRA2B gene in HNSCC and LUSC. Folia Med (Plovdiv) 2024; 66: 673–681.
  12. Eswaramoorthy R. Gene expression analysis of alkaline phosphatase in peri-implantitis tissue. Bioinformation 2023; 19: 506–509.
  13. Sujatha G, Veeraraghavan VP, Alamoudi A, et al. Role of Toothbrushes as Gene Expression Profiling Tool for Oral Cancer Screening in Tobacco and Alcohol Users. Int J Environ Res Public Health 2022; 19: 8052.
  14. Chen Y, Gong W, Dai W, et al. MiR-596 down regulates SOX4 expression and is a potential novel biomarker for gastric cancer. Transl Cancer Res 2020; 9: 1294–1302.
  15. Liu J, Xiao Q, Xiao J, et al. Wnt/β-catenin signalling: function, biological mechanisms, and therapeutic opportunities. Signal Transduct Target Ther 2022; 7: 3.
  16. Liu S-M, Lin C-H, Lu J, et al. miR-596 Modulates Melanoma Growth by Regulating Cell Survival and Death. Journal of Investigative Dermatology 2018; 138: 911–921.
DOI: https://doi.org/10.2478/amma-2025-0007 | Journal eISSN: 2668-7763 | Journal ISSN: 2668-7755
Language: English
Page range: 48 - 52
Submitted on: Dec 7, 2024
Accepted on: Jan 19, 2025
Published on: Apr 1, 2025
Published by: University of Medicine, Pharmacy, Science and Technology of Targu Mures
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2025 P Shereen Farhana, K P Ameya, P P Ashikha Shirin Usman, Durairaj Sekar, published by University of Medicine, Pharmacy, Science and Technology of Targu Mures
This work is licensed under the Creative Commons Attribution 4.0 License.